About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,818 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,818 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4181-4200 of 10,818 trials

TerminatedALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHDThe Balance study will assess the safety, tolerability, and efficacy of an investigational drug called ALPN-101 in adults with steroid-resistant or steroid-refractory acute graft…NCT04227938·Miami, Florida and 3 others CompletedRuxolitinib for Premalignant Breast DiseaseThis study is evaluating how ruxolitinib affects premalignant breast cells.NCT02928978·Birmingham, Alabama and 7 others CompletedFirst-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With ChemotherapyThe purpose of this study was to evaluate the safety and tolerability of VX-984 (M9831) administered alone and in combination with pegylated liposomal doxorubicin (PLD), and to…NCT02644278·Scottsdale, Arizona and 4 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedA Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free DietThe main aim is to see how TAK-062 works to reduce celiac-related symptoms and improve small intestinal damage due to gluten exposure, in participants with celiac disease (CeD)…NCT05353985·Birmingham, Alabama and 101 others

RecruitingSelf-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce…NCT06125743·Philadelphia, Pennsylvania and 1 other

CompletedA Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue SarcomaThe main purpose of this study is to evaluate the efficacy of the combination of doxorubicin plus the study drug known as olaratumab versus doxorubicin plus placebo in…NCT02451943·Duarte, California and 113 others

CompletedA Study of Indinavir Taken With or Without DMP 266The purpose of this study is to see if it is safe and effective to add DMP 266 to an anti-HIV treatment program of indinavir and nucleoside reverse transcriptase inhibitors…NCT00002393·San Francisco, California and 11 others

CompletedCOVID-19 Thrombosis Prevention Trials: Post-hospital ThromboprophylaxisA multicenter, adaptive, randomized platform trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital dischargeNCT04650087·Phoenix, Arizona and 120 others

Active not recruitingA Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.NCT03989414·Denver, Colorado and 48 others

TerminatedA Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy PatientsSubjects with epilepsy with a documented photoparoxysmal response to intermittent photic stimulation (IPS) will participate.NCT00979004·Little Rock, Arkansas and 2 others

TerminatedStudy of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).This is a Phase Ib, open label, dose escalation study of spartalizumab + LAG525 in combination with NIR178, capmatinib, MCS110, or canakinumab, followed by a dose expansion in…NCT03742349·New York, New York and 12 others

CompletedStudy of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)The purpose of this research study is to evaluate the safety and effectiveness of CK-2017357 when taken with or without riluzole (also called Rilutek®) in patients with…NCT01709149·Phoenix, Arizona and 74 others

CompletedA Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced CancerThe main purpose of this study is to investigate the safety of prexasertib in combination with other anti-cancer drugs (cisplatin, cetuximab, pemetrexed, fluorouracil or…NCT02124148·Sarasota, Florida and 4 others

CompletedStudy to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic LeukemiaThe primary objective of the study is to evaluate the safety of idelalisib in combination with an anti-CD20 monoclonal antibody (mAb), a chemotherapeutic agent, a mammalian target…NCT01088048·Huntsville, Alabama and 10 others

RecruitingEvaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast MalignanciesFor patients with breast cancer, it's important to find any remaining cancer cells after they've had their main treatment.NCT07211178·Birmingham, Alabama and 15 others

RecruitingA Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple MyelomaThe purpose of this study is to establish a safe and tolerable dose of arlocabtagene autoleucel (BMS-986393) in combinations with alnuctamab, mezigdomide, iberdomide, and…NCT06121843·Birmingham, Alabama and 18 others

CompletedAccess BNP Clinical Enrollment StudyThe goal of this study is to collect blood from subjects with a suspicion of either new onset or worsened heart failure to be used for testing studies for a new product to aid in…NCT06624293·Loma Linda, California and 16 others

RecruitingClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1Clinical study of ivonescimab for first-line treatment of metastatic NSCLC patients with high PD-L1. Evaluating overall survival and progression free survival.NCT06767514·Chandler, Arizona and 284 others

CompletedRMP-A03 Ocular Suspension in Patients With PterygiumThe goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.NCT05794204·Glendale, California and 5 others

CompletedA Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS TrialThe purpose of this study is to evaluate the long-term safety of the CyPass Micro-Stent in subjects who completed Study Protocol TMI-09-01, COMPASS Trial.NCT02700984·Glendale, Arizona and 21 others

PreviousPage 210 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville